KeyVexKeyVex
Sign in
KeyVex › Disclosures › Executive-branch trades

KeyVex publishes these public financial disclosure filings as news, free and without registration, under the news-media provision of 5 U.S.C. § 13107(c). Source documents are linked on every entry.

Rahul Gupta, N Director, National Drug Control Policy, Office of National Drug Control Policy, disclosed 6 transactions

· Executive-branch trades · U.S. Office of Government Ethics (Form 278-T)

2022-03-08 · purchaseKimberly-Clark Corp. — $15,001 - $50,000
2022-03-25 · saleHP, Inc. — $1,001 - $15,000
2022-03-16 · saleMeta Platforms Inc — $1,001 - $15,000
2022-03-15 · purchaseMeta Platforms Inc — $1,001 - $15,000
2022-03-11 · purchaseMeta Platforms Inc — $1,001 - $15,000
2022-03-10 · purchaseKimberly-Clark Corp. — $15,001 - $50,000

The complete record

Every field KeyVex holds for this filing, as its API serves it. Nothing is withheld here that the API sells.

ownerself
sourceOGE_278T
notifiedfalse
filer nameRahul Gupta
filer typeappointee
report urlhttps://extapps2.oge.gov/201/Presiden.nsf/PAS+Index/1C9153BBB1239EBD85258845002EC56B/$FILE/Rahul-Gupta-04.17.2022-278T.pdf
scraped at2026-06-02T23:33:27.478Z
filing date2022-04-17
filer positionN Director, National Drug Control Policy, Office of National Drug Control Policy

Each transaction (6)

tickerfiling idamount maxamount minasset nameamount rangetransaction datetransaction type
KMBoge-278t-rahul-gupta-2022-04-17-65000015001Kimberly-Clark Corp.$15,001 - $50,0002022-03-08purchase
HPQoge-278t-rahul-gupta-2022-04-17-5150001001HP, Inc.$1,001 - $15,0002022-03-25sale
—oge-278t-rahul-gupta-2022-04-17-4150001001Meta Platforms Inc$1,001 - $15,0002022-03-16sale
—oge-278t-rahul-gupta-2022-04-17-3150001001Meta Platforms Inc$1,001 - $15,0002022-03-15purchase
—oge-278t-rahul-gupta-2022-04-17-2150001001Meta Platforms Inc$1,001 - $15,0002022-03-11purchase
KMBoge-278t-rahul-gupta-2022-04-17-15000015001Kimberly-Clark Corp.$15,001 - $50,0002022-03-10purchase

Original filing document